The HER2-positive breast cancer cell lines chosen for functional analysis are diverse and include the anti-HER2-resistant JIMT-1 and MDA-MB-453, as well as SK-BR-3 and BT-474 which are sensitive to anti-HER2 treatment. The gene discussed is ERBB2; the disease is breast cancer.